Equities

SS Innovations International Inc

SSII:PKC

SS Innovations International Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.65
  • Today's Change0.150 / 4.29%
  • Shares traded21.26k
  • 1 Year change-39.17%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 20:39 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SS Innovations International, Inc. is a developer of surgical robotic technologies. The Company is developing a fully autonomous medical robotic system using software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). Its product range includes its SSI Mantra surgical robotic system, and SSI Mudra is its range of surgical instruments capable of supporting a variety of surgical procedures, including robotic cardiac surgery. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset. The SSi Mantra is comprised of vision cart, which provides an additional 32-inch 3D 4K resolution monitor, identical to the surgeon’s console, for the operating room staff.

  • Revenue in USD (TTM)14.41m
  • Net income in USD-23.68m
  • Incorporated2015
  • Employees239.00
  • Location
    SS Innovations International Inc1600 Se 15Th Street, #512FORT LAUDERDALE 33316United StatesUSA
  • Phone+1 (954) 478-1410
  • Fax+1 (407) 849-2719
  • Websitehttps://ssinnovations.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aura Biosciences Inc0.00-80.69m552.61m88.00--2.89-----1.79-1.790.003.860.00----0.00-39.26---41.21--------------0.00-------30.03------
Sangamo Therapeutics Inc12.28m-249.68m562.20m405.00--23.73--45.79-1.38-1.380.06640.11380.0587--7.4530,313.58-119.44-26.09-153.51-31.04-----2,033.68-136.53----0.00--58.3415.85-34.09---13.25--
Regenxbio Inc84.33m-238.81m572.74m344.00--1.90--6.79-5.03-5.031.766.090.1463--3.27245,136.60-41.43-16.75-51.75-19.0854.3678.27-283.19-72.06----0.00---19.94-16.216.00---5.59--
Celcuity Inc0.00-82.59m581.37m55.00--3.29-----2.74-2.740.004.770.00----0.00-37.03-37.32-39.38-39.16------------0.3525-------57.99---31.12--
Larimar Therapeutics Inc0.00-64.77m592.76m42.00--2.99-----1.15-1.150.003.110.00----0.00-40.11-42.22-43.16-47.14------------0.00-------4.51--8.71--
Alector Inc61.51m-158.41m593.47m241.00--4.99--9.65-1.71-1.710.66071.210.1035----252,082.00-26.66-20.00-35.58-23.81-----257.54-124.07----0.00---27.3628.522.19--4.79--
SS Innovations International Inc14.41m-23.68m597.59m239.00--35.19--41.47-0.1396-0.13960.08470.09950.60032.285.0860,293.01-98.66-161.38-216.15-449.7628.42-79.79-164.35-495.770.9128-45.390.4172-------846.31--159.31--
Corvus Pharmaceuticals Inc0.00-22.62m597.99m28.00--11.67-----0.4458-0.44580.000.81890.00----0.00-36.89-38.31-44.60-43.34-----------22.180.00------34.57---37.45--
ACELYRIN Inc0.00-299.80m604.84m130.00--1.06-----3.06-3.060.005.710.00----0.00-40.33---43.71--------------0.00-------489.21------
Monte Rosa Therapeutics Inc14.98m-119.39m614.34m103.00--2.99--41.02-1.83-1.830.22153.350.0528--33.69112,594.00-42.10---47.48-------797.26------0.00-------24.75------
ProKidney Corp0.00-38.68m622.80m163.00---------0.5905-0.59050.00-7.730.00----0.00-27.97------------------0.0003------67.17------
Terns Pharmaceuticals Inc0.00-95.90m629.62m66.00--2.40-----1.31-1.310.003.110.00----0.00-36.84-41.34-38.72-45.70-------31,010.30----0.00-------49.49---26.60--
Third Harmonic Bio Inc0.00-39.20m632.90m51.00--2.34-----0.9694-0.96940.006.590.00----0.00-13.36---13.66--------------0.00------12.32------
Sana Biotechnology Inc0.00-244.90m642.93m328.00--1.89-----1.15-1.150.001.530.00----0.00-36.94-38.99-42.11-42.70------------0.00-------5.11--112.71--
Alumis Inc0.00-189.03m644.14m128.00---------3.65-3.650.003.87---------------------------142.570.00-------38.47------
Data as of Nov 12 2024. Currency figures normalised to SS Innovations International Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.